Tuesday, August 30th, 2011
When the Prescription Medicines Code of Practice Authority (PMCPA) reprimanded Bayer HealthCare this month for breaching the ABPI Code of Practice in two of the company’s postings on Twitter, the ruling may have exacerbated wariness about social media within the pharmaceutical industry.
Industry sources say, though, that drug companies should not ...
Posted in
Social media in pharma, adherence and compliance |
2 Comments »
Wednesday, June 10th, 2009
Recently, FDA issued a draft guidance titled Presenting Risk Information in Prescription Drug and Medical Device Promotion. The draft guidance outlines factors FDA considers when evaluating ads and labeling for prescription drugs, providing examples to illustrate the agency’s thinking. According to FDA, the guidance was issued in response to requests ...
Posted in
FDA Files, Sales & Marketing |
1 Comment »
|
|
